Format

Send to

Choose Destination
Gynecol Oncol. 2017 Nov;147(2):433-438. doi: 10.1016/j.ygyno.2017.08.028. Epub 2017 Sep 7.

Values and worries of ovarian cancer patients.

Author information

1
Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: mpisu@uab.edu.
2
Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States; Institute for Cancer Outcomes and Survivorship and Division of Hematology Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
3
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.
4
Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.
5
Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States.
6
Department of Obstetrics and Gynecology, School of Medicine, Vanderbilt University, Nashville, TN, United States.
7
Division of Gynecologic Oncology, Northside Hospital, Atlanta, GA, United States.
8
Division of Gynecologic Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, United States.
9
Center for Innovation in Health Equity Research (CIHER), Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.

Abstract

INTRODUCTION:

Older women with ovarian cancer (OC) are less likely to receive guideline concordant treatment. Differences in values and worries about treatment may explain why.

METHODS:

Women with OC in 2013-2015 were surveyed about values and worries at the time of initial treatment. Existing values (11 item, e.g., maintaining quality of life) and worries (12 items, e.g., treatment side effects) scales were adapted based on OC literature. Responses were very/somewhat/a little/not at all important or worried. Principal Component Analyses (PCA) identified groups of values and worries that best explained scales' variation. We examined proportions reporting very/somewhat important/worried on ≥1 item in each component by age (older ≥65years, younger <65years).

RESULTS:

Of 170 respondents, 42.3% were older. PCA components for values were: functional well-being (3 survey items, proportion of variance explained [PoVE] 26.3%), length of life and sexual functioning (3 items, PoVE 20.1%), attitudes (3 items, PoVE 14.2%), and not becoming a burden (2 items, PoVE 13.7%). PCA components for worries were: economic (4 items, PoVE 27.2%), uncertainty (6 items, PoVE 26.0%), and family impact (2 items, PoVE 16.3%). Older women were less likely to indicate very/somewhat worried to ≥1 item in the economic (51.4% vs 72.4%, p=0.006), uncertainty (80.6% vs. 98.0%, p=0.001), and family impact component (55.6% vs. 70.4%, p=0.03). No other age differences were found.

CONCLUSIONS:

While worry during OC treatment decision-making may differ across age groups, values do not. Research should assess how differences in worry might affect OC medical decision-making for older and younger women.

KEYWORDS:

Gynecologic oncology; Ovarian cancer; Treatment decision making; Values; Worries

PMID:
28888542
PMCID:
PMC5835401
DOI:
10.1016/j.ygyno.2017.08.028
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center